Table 3.
Variables | NAFLD patients (N=59) |
Controls (N=22) |
P-value |
---|---|---|---|
Age (years) | 51±11 | 55±11 | 0.100 |
Waist circumference (cm) | 106±12 | 92±10 | <0.001 |
BMI (kg/m2) | 30±4.7 | 26±4 | <0.001 |
Smoking (%) | 32.7 | 27.8 | 0.695 |
eGFR (mL/min/1.73 m2) | 80±2 | 81±2 | 0.802 |
Hypertension (%) | 76.3 | 86.4 | 0.321 |
Office SBP (mmHg) | 153±19 | 149±13 | 0.290 |
Office DBP (mmHg) | 93±13 | 91±8 | 0.526 |
24-hour mean SBP (mmHg) | 135±13 | 131±10 | 0.168 |
24-hour mean DBP (mmHg) | 84±11 | 83±7 | 0.716 |
Daytime mean SBP (mmHg) | 141±14 | 137±9 | 0.300 |
Daytime mean DBP (mmHg) | 89±11 | 88±7 | 0.816 |
Nighttime mean SBP (mmHg) | 122±16 | 119±12 | 0.316 |
Nighttime mean DBP (mmHg) | 73±11 | 71±8 | 1.000 |
Morning mean SBP (mmHg) | 133±15 | 131±13 | 0.549 |
Morning mean DBP (mmHg) | 84±11 | 83±7 | 0.813 |
White-coat hypertension (%) | 11.9 | 12.5 | 0.293 |
AST (IU/L) | 25±11 | 20±7 | 0.097 |
ALT (IU/L) | 39±31 | 32±36 | 0.439 |
GGT (IU/L) | 30±18 | 21±12 | 0.038 |
ALP (IU/L) | 93±55 | 78±44 | 0.796 |
CHOL (mg/dL) | 220±39 | 212±37 | 0.265 |
LDL (mg/dL) | 148±46 | 136±30 | 0.205 |
HDL (mg/dL) | 49±16 | 56±16 | 0.147 |
TRIGL (mg/dL) | 138±75 | 109±50 | 0.127 |
Hs-CRP (mg/dL) | 1.25±1.75 | 0.74±0.69 | 0.314 |
GLU (mg/L) | 99±16 | 93±8 | 0.112 |
Notes: Data are presented as mean ± standard deviation. Upper reference limits are 45 IU/L for AST, 45 IU/L for ALT, 55 IU/L for GGT, 150 IU/L for ALP, 200 mg/dL for CHOL, 140 mg/dL for LDL, 160 mg/dL for TRIGL, 5 mg/L for Hs-CRP, and 110 mg/dL for GLU in our laboratory. Lower reference limit is 35 mg/dL for HDL in our laboratory.
Abbreviations: NAFLD, nonalcoholic fatty liver disease; eGFR, estimated glomerular filtration rate; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyl transpeptidase; ALP, alkaline phosphatase; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TRIGL, triglycerides; Hs-CRP, high-density c-reactive protein; GLU, glucose serum fast.